Bio Essence (BIOE) Cash from Financing Activities (2020 - 2026)

Bio Essence's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $448147.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 1714.51% year-over-year to $448147.0; the TTM figure through Mar 2026 stood at -$1.1 million (down 50.99% YoY), while the FY2025 annual figure was -$1.6 million, down 156.23% from the prior year.
• Cash from Financing Activities was $448147.0 for Q1 2026 at Bio Essence, up from -$1.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $448147.0 in Q1 2026 to a low of -$1.3 million in Q4 2025.
• Historically, Cash from Financing Activities has averaged $16376.2 across 5 years, with a median of $182782.0 in 2022.
• The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities slumped 4872.38% in 2025, then surged 1714.51% in 2026.
• A 5-year view of Cash from Financing Activities shows it stood at $207586.0 in 2022, then soared by 50.48% to $312384.0 in 2023, then sank by 244.54% to -$451513.0 in 2024, then tumbled by 181.23% to -$1.3 million in 2025, then jumped by 135.29% to $448147.0 in 2026.
• The last three Cash from Financing Activities figures came in at $448147.0 (Q1 2026), -$1.3 million (Q4 2025), and -$158232.0 (Q3 2025), per Business Quant data.